BIT/1BSX (BIT/1BSX)

Borsa Italiana: BIT/1BSX · EUR

€38.1

-0.36 (-0.9%)· Recorded snapshot

Market cap	58.6B
Revenue (ttm)	18.4B
Net income (ttm)	3.2B
EPS (ttm)	€2.22
P/E (trailing)	17.2x
P/E (forward)	13.9x
Volume	4

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.4B
Net income (ttm): 3.2B
EPS (ttm): €2.22
P/E (trailing): 17.2x
P/E (forward): 13.9x
Market cap: 58.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E13.9

P25 13.7P50 18.9P75 26.3

Trailing P/E17.2

P25 18.3P50 24.5P75 35.6

ROE15.3

P25 2.4P50 10.6P75 22.2

ROIC11.2

P25 5.1P50 9P75 18.8

Benchmarks · 1M

All BIT/1BSX indicators

Market & fundamental data

Available fields

235

Groups with data

Currency

USD

Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-10-28
Employees	59,000
Employees change	6,000
Employees growth	11.32%
Enterprise value	EUR 69.7B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1979
Industry	Medical Devices
Is primary listing	No
ISIN number	US1011371077
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Market cap	EUR 58.6B
Next earnings date	2026-10-28
Price	EUR 38.07
Price currency	EUR
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-02
Symbol	bit/1BSX
Website	https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	86.63x
Average P/E ratio (3Y)	54.88x
Average P/E ratio (5Y)	64.8x
Earnings yield	5.83%
EV/Earnings	21.67x
EV/EBIT	18.06x
EV/EBITDA	13.59x
EV/FCF	21.96x
EV/Sales	3.7x
FCF / EV yield	4.55%
FCF yield	5.41%
Forward P/E	13.89x
Graham number	25.93562
Graham upside	-31.87%
Lynch fair value	EUR 52.22
Lynch upside	37.17%
P/(FCF - SBC) ratio	20.26x
P/(OCF - SBC) ratio	15.91x
P/B ratio	2.66x
P/E ratio	17.16x
P/FCF ratio	18.47x
P/OCF ratio	14.78x
P/S ratio	3.19x
Price/EBITDA ratio	11.72x
Sector forward P/E	16.78x
Sector P/E	20.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	20.47%
EBITDA margin	27.2%
Effective tax rate	5%
FCF margin	16.81%
Gross margin	69.19%
Operating margin	20.47%
Pretax margin	18.39%
Profit margin	17.5%
Profit per employee	EUR 54,506
Profitable quarters	23
Profitable years	5
Revenue per employee	EUR 311,488
ROA	6.19%
ROA (5Y)	4.61%
ROCE	11.08%
ROE	15.34%
ROE (5Y)	8.1%
ROIC	11.2%
ROIC (5Y)	7.52%
SBC / revenue	1.52%
Tax / revenue	0.92%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	46.9%
EPS growth (Q)	15.09%
EPS growth (QoQ)	-32.22%
EPS growth 3Y	60.29%
EPS growth 5Y	46.22%
EPS growth quarters	7
EPS growth years	3
FCF growth	4.02%
FCF growth (Q)	13.29%
FCF growth (QoQ)	647.95%
FCF growth 3Y	33.93%
FCF growth 5Y	14.35%
Gross profit growth	14.37%
Gross profit growth (Q)	12.49%
Gross profit growth 3Y	16.17%
Gross profit growth 5Y	13.16%
Net income growth	46.67%
Net income growth (Q)	13.8%
Net income growth (QoQ)	-32.36%
Net income growth 3Y	62.2%
Net income growth 5Y	47.51%
Net income growth quarters	7
Net income growth years	3
OCF growth	5.69%
OCF growth (Q)	14.62%
OCF growth (QoQ)	323.56%
OCF growth 10Y	13.52%
OCF growth 3Y	28.69%
OCF growth 5Y	15.09%
Operating income growth	22.52%
Operating income growth (Q)	32.13%
Operating income growth 3Y	24.58%
Operating income growth 5Y	18.97%
Revenue growth	13.53%
Revenue growth (Q)	7.53%
Revenue growth (QoQ)	4.59%
Revenue growth 10Y	10.3%
Revenue growth 3Y	16.15%
Revenue growth 5Y	13.4%
Revenue growth quarters	22
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -791.3M
Depreciation and amortization	EUR 1.3B
EBIT	EUR 3.8B
EBITDA	EUR 5B
EPS	EUR 2.22
Financing cash flow	EUR -838.5M
Free cash flow	EUR 3.2B
Free cash flow minus SBC	EUR 2.9B
Gross profit	EUR 12.7B
Income taxes	EUR 168.9M
Investing cash flow	EUR -3.1B
Net borrowing	EUR 879.1M
Net cash flow	EUR 10.5M
Net income	EUR 3.2B
Operating cash flow minus SBC	EUR 3.7B
Operating income	EUR 3.8B
Revenue	EUR 18.4B
Stock-based compensation	EUR 280.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.8
Book value per share	EUR 15.08
Debt / EBITDA	2.21
Debt / equity	0.5
Debt / FCF	3.48
Goodwill	EUR 16.8B
Interest coverage	11.84
Long-term assets	EUR 32.4B
Long-term liabilities	EUR 11.8B
Net cash (debt)	EUR -10.6B
Net cash / market cap	-18.05%
Net debt / EBITDA	2.12
Net debt / equity	0.48
Net debt / FCF	3.33
Piotroski F-Score	7
Property, plant and equipment	EUR 4.2B
Shareholders' equity	EUR 22B
Tangible book value	EUR -549.7M
Tangible book value per share	EUR -0.38
Total assets	EUR 39.6B
Total cash	EUR 471.8M
Total debt	EUR 11B
Total liabilities	EUR 17.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current assets	EUR 7.2B
Current liabilities	EUR 5.8B
Current ratio	1.24
Inventory turnover	2.12
Net working capital	EUR 2.4B
Quick ratio	0.56
Working capital	EUR 1.4B
Working capital turnover	10.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.05%
Shareholder yield	0.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 45.53
1D price change	-0.92%
1M price change	-7.09%
1M total return	-7.09%
1W price change	-3.68%
1W total return	-3.68%
1Y price change	-52.77%
1Y return CAGR	-52.79%
1Y total return	-52.77%
20-day SMA	EUR 38.59
200-day SMA	EUR 52.54
3M price change	0.61%
3M total return	0.61%
3Y price change	-24.19%
3Y return CAGR	-8.82%
3Y total return	-24.19%
50-day SMA	EUR 40.80
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 92.00
52-week high date	2025-11-17
52-week low	EUR 37.00
52-week low date	2026-09-11
5Y price change	1.39%
5Y return CAGR	0.28%
5Y total return	1.39%
6M price change	-30.02%
6M total return	-30.02%
All-time high	EUR 103.00
All-time high date	2025-02-10
All-time low	EUR 23.19
All-time low date	2020-03-23
Average true range (ATR)	EUR 0.69
Average volume	419.4
Change from 52-week high	-58.62%
Change from 52-week low	2.91%
Change from all-time high	-63.04%
Change from all-time low	64.17%
Change from open	-1.08%
Day's gap	0.16%
Dollar volume	EUR 152
High price	EUR 38.49
Low price	EUR 38.49
Monthly RSI	28.09
Open price	EUR 38.49
Previous close	EUR 38.43
Price vs 150-day SMA	-16.38%
Price vs 20-day SMA	-1.34%
Price vs 200-day SMA	-27.55%
Price vs 50-day SMA	-6.69%
Relative volume	0.01
RSI	42.68
Sharpe ratio	-1.98
Sharpe ratio (3Y)	-0.29
Sharpe ratio (5Y)	0
Sortino ratio	-2.28
Sortino ratio (3Y)	-0.2
Sortino ratio (5Y)	0.21
Volume	4
Weekly RSI	33.73
YTD price change	-53.23%
YTD total return	-53.23%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4B
Shares change (QoQ)	-1.35%
Shares change (YoY)	-0.05%
Shares held by insiders	0.18%
Shares held by institutions	93.19%
Short ratio	2.1 days

Deeper analysis on BIT/1BSX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1BSX report

Is a complete BIT/1BSX research report available?

No complete published report is available for bit/1BSX (BIT/1BSX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1BSX (BIT/1BSX)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1BSX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1BSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1BSX

Frequently asked questions